TG21 Plc
12 April 2006
Immediate Release: Wednesday 12 April 2006
TG21 plc
('TG21' or 'the Group' or 'the Company')
Issue of share options to directors
The Board of TG21 announces that the Company has today issued 500,000 share
options over 10p ordinary shares in the Company to each of Nick Grimond, Wilson
Jennings and Peter Ward. These have been issued under the TG21 plc Enterprise
Management Incentive Plan. These share options are exercisable subject to the
achievement of profit targets for the Group and must be exercised within ten
years from the date of grant. In addition, 75,000 share options over 10p
ordinary shares have been issued to David Voss under a non-executive director
share option scheme and these options must be exercised between three and ten
years of the date of grant. All of the options are exercisable at 12.5p per
share.
-Ends-
For enquiries please contact:
Peter Ward
Chairman, TG21 plc
Wilson Jennings
Finance Director, TG21 plc
Tel: 020 8710 4000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.